Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
108
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD

Chih-Cheng Lai1 Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan
,
Ya-Hui Wang2 Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan
,
Cheng-Yi Wang3 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, TaiwanCorrespondence[email protected]
,
Hao-Chien Wang4 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
,
Chong-Jen Yu4 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
&
Likwang Chen5 Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan
Pages 867-874 | Published online: 08 Mar 2018

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhishen Ruan, Dan Li, Yuanlong Hu, Zhanjun Qiu & Xianhai Chen. (2022) The Association of Renin-Angiotensin System Blockades and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2001-2011.
Read now

Articles from other publishers (28)

A. I. Gordeev, L. D. Khidirova, S. A. Kalenova, Z. M. Osmieva & A. A. Vasilenko. (2023) Arterial stiffness as therapeutic target for smokers with comorbidity. Medical alphabet:4, pages 39-44.
Crossref
Chiung-Hung Lin, Jih-Kai Yeh, Ting-Yu Lin, Yu-Lun Lo, Bo-Jui Chang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Yun-Ju Huang & Shu-Min Lin. (2023) Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction. BMC Pulmonary Medicine 23:1.
Crossref
Hongzhen Lv, Jingyi Huang, Miao Miao, Cheng Huang, Wenlu Hang & Yong Xu. (2023) Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis. BMJ Open Respiratory Research 10:1, pages e001569.
Crossref
Jana Heidemann, Marcel Konrad, Christoph Roderburg, Sven H. Loosen & Karel Kostev. (2022) Association between Antihypertensive Therapy and Risk of Acute Lower Respiratory Infections (ALRI): A Retrospective Cohort Study. Healthcare 10:11, pages 2318.
Crossref
Xiao-Fang Li, Cheng-Quan Wan & Yi-Min Mao. (2022) Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease. Frontiers in Medicine 9.
Crossref
Fumiki Yoshihara, Hiroshi Ohtsu, Michikazu Nakai, Shinya Tsuzuki, Kayoko Hayakawa, Mari Terada, Nobuaki Matsunaga, Satoshi Yasuda, Hisao Ogawa & Norio Ohmagari. (2022) Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan. Journal of Cardiology 80:4, pages 292-297.
Crossref
Hideki Tsunoda, Yukiko Okami, Yuki Honda, Akihiro Shiroshita, Yuki Kataoka, Yasushi Tsujimoto & Kazuhiro Matsumura. (2022) Effectiveness of angiotensin converting enzyme inhibitors in preventing pneumonia: A systematic review and meta‐analysis. Journal of General and Family Medicine 23:4, pages 217-227.
Crossref
Aimin Yang, Mai Shi, Hongjiang Wu, Eric SH Lau, Baoqi Fan, Alice PS Kong, Ronald CW Ma, Andrea OY Luk, Juliana CN Chan & Elaine Chow. (2022) Time-varying risk associations of renin angiotensin system inhibitors with pneumonia and related deaths in a cohort of 252,616 patients with diabetes (2002–2019). Diabetes Research and Clinical Practice 185, pages 109233.
Crossref
Jae-Hyun Yun, Seung Yeon Rhee, Sungyoun Chun, Hyoung Seop Kim & Byung-Mo Oh. (2022) Association Between Antihypertensive Use and Hospitalized Pneumonia in Patients With Stroke: A Korean Nationwide Population-Based Cohort Study. Journal of Korean Medical Science 37:15.
Crossref
Eleanor L Axson, Alex Bottle, Martin R Cowie & Jennifer K Quint. (2021) Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax 76:8, pages 807-814.
Crossref
Soumeya Abed, Rebecca Turner, Nickolas Serniuck, Victor Tat, Safaa Naiel, Aaron Hayat, Olivia Mekhael, Megan Vierhout, Kjetil Ask & Anthony F. Rullo. (2021) Cell-specific drug targeting in the lung. Biochemical Pharmacology 190, pages 114577.
Crossref
Masoud Nouri‐Vaskeh, Niusha Kalami, Ramin Zand, Zahra Soroureddin, Mojtaba Varshochi, Khalil Ansarin, Haleh Rezaee, Ali Taghizadieh, Armin Sadeghi, Masoud Ahangari Maleki, Azam Esmailnajad, Parviz Saleh, Mehdi Haghdoost, Mehdi Maleki & Akbar Sharifi. (2021) Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial. International Journal of Clinical Practice 75:6.
Crossref
Stormi E. Gale, Andrew Mardis, Michael E. Plazak, Alina Kukin & Brent N. Reed. (2021) Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:6, pages 537-545.
Crossref
Juan M. Saavedra. (2021) Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology 36:3, pages 160-173.
Crossref
Farhan Chaudhry, Sergio Lavandero, Xiang Xie, Basera Sabharwal, Ying-Ying Zheng, Ashish Correa, Jagat Narula & Phillip Levy. (2020) Manipulation of ACE2 expression in COVID-19. Open Heart 7:2, pages e001424.
Crossref
Marcello Covino, Giuseppe De Matteis, Maria Livia Burzo, Michele Santoro, Mariella Fuorlo, Luca Sabia, Claudio Sandroni, Antonio Gasbarrini, Francesco Franceschi & Giovanni Gambassi. (2020) Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19. Internal Medicine Journal 50:12, pages 1483-1491.
Crossref
Abdel G. Elkahloun & Juan M. Saavedra. (2020) Candesartan could ameliorate the COVID-19 cytokine storm. Biomedicine & Pharmacotherapy 131, pages 110653.
Crossref
Jaroslav Hrenak & Fedor Simko. (2020) Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences 21:21, pages 8038.
Crossref
Timothy M.E. Davis & Wendy A. Davis. (2020) Influence of Renin-Angiotensin System Inhibitors on Lower–Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes Care 43:9, pages 2113-2120.
Crossref
Wagner Gouvea dos Santos. (2020) Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomedicine & Pharmacotherapy 129, pages 110493.
Crossref
H. A. Tymchenko & Anton Viktorovych Rohozhyn. (2020) APPROACHES TO COMBINED TREATMENT OF PATIENTS WITH CARDIOPULMONARY PATHOLOGY. International Medical Journal:2, pages 11-15.
Crossref
Nicholas E. Ingraham, Abdo G. Barakat, Ronald Reilkoff, Tamara Bezdicek, Timothy Schacker, Jeffrey G. Chipman, Christopher J. Tignanelli & Michael A. Puskarich. (2020) Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review. European Respiratory Journal 56:1, pages 2000912.
Crossref
Juan M. Saavedra. (2020) COVID-19, Angiotensin Receptor Blockers, and the Brain. Cellular and Molecular Neurobiology 40:5, pages 667-674.
Crossref
Peng ZhangLihua ZhuJingjing CaiFang LeiJuan-Juan QinJing Xie, Ye-Mao LiuYan-Ci ZhaoXuewei HuangLijin LinMeng XiaMing-Ming ChenXu ChengXiao Zhang, Deliang Guo, Yuanyuan Peng, Yan-Xiao JiJing ChenZhi-Gang SheYibin WangQingbo XuRenfu Tan, Haitao Wang, Jun Lin, Pengcheng Luo, Shouzhi Fu, Hongbin CaiPing YeBing XiaoWeiming MaoLiming LiuYouqin YanMingyu LiuManhua ChenXiao-Jing ZhangXinghuan Wang, Rhian M. TouyzJiahong Xia, Bing-Hong Zhang, Xiaodong Huang, Yufeng Yuan, Rohit LoombaPeter P. LiuHongliang Li. (2020) Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circulation Research 126:12, pages 1671-1681.
Crossref
Josuel Ora, Francesco Cavalli & Mario Cazzola. 2020. Cardiovascular Complications of Respiratory Disorders. Cardiovascular Complications of Respiratory Disorders 66 81 .
L. G. Ambatiello & I. E. Chazova. (2020) Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics. Terapevticheskii arkhiv 92:3, pages 78-83.
Crossref
M. L. Hepworth, S. L. Passey, H. J. Seow & R. Vlahos. (2019) Losartan does not inhibit cigarette smoke-induced lung inflammation in mice. Scientific Reports 9:1.
Crossref
Klaus F. Rabe, John R. Hurst & Samy Suissa. (2018) Cardiovascular disease and COPD: dangerous liaisons?. European Respiratory Review 27:149, pages 180057.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.